LOXO-195 [2097002-61-2]
L589938
![LKT Laboratories](https://www.bio-connect.nl/wp-content/uploads/2024/02/LKT-Laboratories_logo.png)
Overview
- SupplierLKT Laboratories
- Product NameLOXO-195 [2097002-61-2]
- Delivery Days Customer7
- Estimated Purity≥99%
- FormatEthanol (3 mg/mL), DMSO (5 mg/mL), DMF (12 mg/mL).
- Scientific DescriptionInhibitor of TRK.; LOXO195; 0J45910S3X; Selitrectinib
- Storage Instruction-20°C
- UNSPSC12352200
References
- Parikh AR, Corcoran RB. Fast-tracking drug development for rare molecular targets. Cancer Discov. 2017 Sep;7(9):934-936. PMID: 28864638. Drilon A, Nagasubramanian R, Blake JF, et al. A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors. Cancer Discov. 2017 Sep;7(9):963-972. PMID: 28578312.